Cytotoxicity of PEGylated liposomes co-loaded with novel pro-apoptotic drug NCL-240 and the MEK inhibitor cobimetinib against colon carcinoma in vitro
- 1 December 2015
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 220, 160-168
Abstract
No abstract availableKeywords
Funding Information
- FAPESP (2014/03228-5)
- NIH (U54CA151881)
This publication has 39 references indexed in Scilit:
- Barriers to drug delivery in solid tumorsTissue Barriers, 2014
- Combination PI3K/MEK inhibition promotes tumor apoptosis and regression in PIK3CA wild-type, KRAS mutant colorectal cancerCancer Letters, 2014
- MEK in cancer and cancer therapyPharmacology & Therapeutics, 2014
- Characteristics of sequential targeting of brain glioma for transferrin-modified cisplatin liposomeInternational Journal of Pharmaceutics, 2013
- Micellar formulations of pro-apoptotic DM-PIT-1 analogs and TRAILin vitroandin vivoDrug Delivery, 2013
- ERK implication in cell cycle regulationBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007
- Targeted delivery of RNA-cleaving DNA enzyme (DNAzyme) to tumor tissue by transferrin-modified, cyclodextrin-based particlesCancer Biology & Therapy, 2004
- p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groupsBiochimica et Biophysica Acta (BBA) - Biomembranes, 2001
- On the use of the Kolmogorov-Smirnov statistical test for immunofluorescence histogram comparisonCytometry, 2000
- A NEW CONCEPT FOR MACROMOLECULAR THERAPEUTICS IN CANCER-CHEMOTHERAPY - MECHANISM OF TUMORITROPIC ACCUMULATION OF PROTEINS AND THE ANTITUMOR AGENT SMANCS1986